Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2026-02-08 @ 1:59 PM
Study NCT ID:
NCT04238195
Status:
COMPLETED
Last Update Posted:
2020-03-13
First Post:
2020-01-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single-Dose, Randomized, Placebo- and Active-Control, Four-Way, Cross-Over Study for the Evaluation of the Effect of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) on the QT/QTc Intervals in Adult Healthy Subjects
Sponsor:
Spero Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SPR994-104
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |